assessment of erectile disclosure slide …...impotence impotence is the inability to achieve or...
TRANSCRIPT
15/10/2014
1
ASSESSMENT OF ERECTILE DYSFUNCTION
Dr Michael Gillman
• St Andrews Hospital –North St Specialist Suites
• Mater Hospital – 3rd Floor Mater Private Clinic
• Wesley Hospital Suite 5 Level 9 Evan Thomson Bld
• Cleveland- Shore Street West Medical Centre
Disclosure Slide
Advisor Lilly Australia Cialis and Axiron
Advisor Pfizer Australia Viagra / Caverject
Advisor Bayer Levitra
Advisor Andrology Australia Erectile Dysfunction Board
Advisor Menarini Priligy
Advisor Sanofi Adventis Xatral
Advisor CSL Flomaxtra
IMPOTENCE
Impotence is the inability to achieve or sustain an erection sufficient for the sexual needs of the man
or his partner
ERECTILE DIFFICULTIES
40% at age 40
50% at age 50
60% at age 60
70% at age 70
Do Men Really Care???
How many of your male patients book appointments to discuss erection problems ?
15/10/2014
2
Erectile Dysfunction History – Main Points
Duration of onset of problem.
Quality of all erections ( Spontaneous and sexual )
Relationship issues
Previous Treatments including Newspaper Commercial Clinics
Erectile Dysfunction History – Main Points
>70% have an organic component
Assume that most men have both Organic and Psychogenic
Psychogenic
Mainly Performance anxiety
Relationship Difficulties
Financial Difficulties
etc
15/10/2014
3
Diabetes Hypertension
The Deadly Quartet
Obesity Dyslipidemia
Why does ED occur earlier than cardiovascular disease?
Artery Diameter (mm) Critical events
Penile 1–2 Erectile
dysfunction
Coronary 3–4 Angina / MI
Carotid 5–7 TIA / Stroke
Adapted from Montorsi et al. Am J Cardiol 2005; 96: 19M–23M
The arterial size hypothesis
Examination
Examination
BP
Height Weight and waist circumference
Penile shaft for fibrosis
Testicles
Vascular system AAA, peripheral pulses
? Prostate with informed consent
Investigations
Renal and Liver Function Tests HDL/LDL
Testosterone ( LH and PRL if low ) TSH
Urine WTU ?PSA
15/10/2014
4
Testosterone and ED ??
• Low testosterone is an uncommon cause of ED
• However PDE 5 inhibitors do not work as well in the presence of low testosterone
• Free Androgen Index, Bioavailable Index and Free Testosterone are unreliable and generally not used
• “best of a bad bunch” is two morning sample serum testosterone levels
TREATMENT
Counselling
Viagra Cialis, Levitra, Uprima ( Not Yet Available )
Intracavernosal Injections ( Caverject and Combinations)
Trans-urethral Agents (MUSE) ( Not currently available)
Topiglans ( Not yet available )
Vacuum Devices
Penile implants
Low intensity Extracorporeal shockwave device
Testosterone
Vascular Surgery ( Selected Cases Only )
VACUUM DEVICES
15/10/2014
5
INTRACAVERNOSAL INJECTIONS
SELF INJECTION THERAPY (cont)
Side effects Scarring ?? No real evidence of this is injection
performed correctly
priapism
bruising
pain
Follow up at one month, then every six months as
appropriate
15/10/2014
6
PRIAPISM
The only real side-effect of injections
Prolonged erection not associated with sexual stimulation
After 24 hours may have irreversible cavernosal damage resulting in permanent erectile dysfunction
Must have action plan
Not usual with PDE5 inhibitors alone
INTRACAVERNOSAL IMPLANTS
Three – Piece Inflatable Penile Implant
Simple to use
Totally concealed within body
Acts and feels like a natural erection
Provides fullness and girth expansion
Softer and more flaccid when deflated
Disadvantages
Requires some manual dexterity
Possibility of malfunction
Possibility of leakage
Shockwave Therapy
15/10/2014
7
Extracorporeal Shockwave Therapy
Extracorporeal Shockwave Therapy
• Electrical energy is converted into acoustic shockwaves.
• When shockwaves come into contact with the endothelial wall there is the creation of cavitation forced, sheer stress and tissue radical formation.
• This has been shown to improve perfusion (1)
• Also shown to increase NO production (2) • 1. Aicher et al Shockwave Therapy Recruits Systematically Infused Endothelial Progenitor Cells Presented at AHA convention Nov 2005
• 1. Mariotto et al Extracorporeal shockwaves: from Lithotripsy to anti-inflammatory action by NO production 12(2):89-96 Mar 2005
Extracorporeal Shockwave Therapy
• Assumed that ECSWT may provide a rehabilitative or curative effect for ED
• Studies are underway at many centres and preliminary results show an improvement in IIEF of around 7 at 6 months
• ECSWT is applied at various points along the penile shaft and on the penile crura. Each treatment last around 20 mins and usual number of treatments is 12
• May have a role in men with vascular aetiology who are poor responders to PDE5 inhibitors
PDE5’s ARE DISCOVERED!!!!!!
15/10/2014
8
Oral Agents
Needs sexual stimulation to work
Allow time
On demand or daily dosing
Tailor management to individual couple Cost
Convenience
Efficacy
Side effects
The Role of PDE5 Inhibitors in Achieving and Maintaining Erection
cGMP-specific
protein kinase
Endothelial
cell
Guanylate
cyclase
GT
P
cGMP
K+
Ca2+
Decreased
Ca2+
Smooth
muscle
relaxation
& erection
Nitric
oxide
Smooth muscle cell
5'GMP PDE5
Cavernous
nerve
Sexual Stimulation
PDE5 Inhibitors
CHANCE OF A “CURE”????
CAVERNOSAL HYPOXIA
Aging effects on the corporal vasculature supply (hyperlipidaemia, hyperglycaemia etc.) cause hypoxic changes
Transforming Growth Factor TGF-B(1) is inhibited by prostaglandin
PGE(1&2) suppress collagen synthesis in human fibroblast cultures
CAVERNOSAL HYPOXIA (cont)
An imbalance between PGE and TGF-B(1) in the corpora due to hypoxia, may cause increased extracellular matrix deposition, inhibition of smooth muscle growth, and eventually fibrosis
PGE may have a role in the management of cavernosal fibrosis
15/10/2014
9
Main Points
Take a good history
Ask at risk patients about sexual function
Offer patients a range of options
Discuss pros and cons of each
Ensure they use product effectively
They do grow on trees!